MRK vs TMO
By Alex · Tickerpine
Merck & Co., Inc. vs Thermo Fisher Scientific Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | TMO |
|---|---|---|
| Price | $147.76 | $700.22 |
| Market cap | $364.26B | $259.44B |
| P/E ratio | 149.3 | 36.9 |
| ROE | 5.06% | 13.38% |
| Profit margin | 3.64% | 14.94% |
| Revenue growth | 4.70% | 9.10% |
| Dividend yield | 2.30% | 0.27% |
| Beta | 0.12 | 0.84 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs TMO in plain English
- MRK is the bigger company — about 1.4× the market cap of TMO.
- TMO is cheaper on earnings (P/E 36.9 vs 149.3).
- TMO earns a higher return on equity (13% vs 5%).
- TMO is growing revenue faster (9% vs 5%).
- MRK has the higher dividend yield (2.30% vs 0.27%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.